Alsheikh-Ali, A. A., W. Qureshi, M. H. Al-Mallah, and J. P. Ioannidis. 2011. Public availability of published research data in high-impact journals. PLoS ONE 6(9):e24357.
Alston, C., L. Paget, G. Halvorson, B. Novelli, J. Guest, P. McCabe, K. Hoffman, C. Koepke, M. Simon, S. Sutton, S. Okun, P. Wicks, T. Undem, V. Rohrbach, and I. Von Kohorn. 2012. Communicating with patients on health care evidence. Discussion Paper, Institute of Medicine, Washington, DC. http://www.iom.edu/evidence (accessed March 7, 2013).
Antithrombotic Trialists’ Collaboration. 2002. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71-86. Erratum in: BMJ, 2002, 324(7330):141.
Baigent, C., A. Keech, P. M. Kearney, L. Blackwell, G. Buck, C. Pollicino, A. Kirby, T. Sourjina, R. Peto, R. Collins, R. Simes, and Cholesterol Treatment Trialists’ (CTT) Collaborators. 2005. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267-1278. Errata in: Lancet, 2008, 371(9630):2084; Lancet, 2005, 366(9494):1358.
Califf, R. M., R. A. Harrington, L. K. Madre, E. D. Peterson, D. Roth, and K. A. Schulman. 2007. Curbing the cardiovascular disease epidemic: Aligning industry, government, payers, and academics. Health Affairs (Millwood) 26(1):62-74.
Chalmers, I. 2006. TGN1412 and the Lancet’s solicitation of reports of Phase I trials. Lancet 368(9554):2206-2207.
Eichler, H.-G., E. Abadie, A. Breckenridge, H. Leufkens, and G. Rasi. 2012. Open clinical trial data for all? A view from regulators. PLoS Medicine 9(4):e1001202.
EMA (European Medicines Agency). 2012. Access to clinical-trial data and transparency: Workshop report. http://www.ema.europa.edu/docs/en_GB/document_library/Report/2012/12/WC500135841.pdf
(accessed March 7, 2013).
Gøtzsche, P. C. 2011. Why we need easy access to all data from all clinical trials and how to accomplish it. Trials 12:249.
Hart, B., A. Lundh, and L. Bero. 2012. Effect of reporting bias on meta-analyses of drug trials: Reanalysis of meta-analyses. BMJ 344:d7202.
HEW (Department of Health, Education and Welfare). 1979. The Belmont Report: Ethical principles and guidelines for the protection of human subjects of research. http://www.hhs.gov/ohrp/humansubjects/guidance/belmont.html (accessed March 7, 2013).
Hrachovec, J. B., and M. Mora. 2001. Reporting of 6-month vs. 12-month data in a clinical trial of celecoxib. JAMA 286(19):2398; author reply 2399-2400.
Ioannidis, J. P., D. B. Allison, C. A. Ball, I. Coulibaly, X. Cui, A. C. Culhane, M. Falchi, C. Furlanello, L. Game, G. Jurman, J. Mangion, T. Mehta, M. Nitzberg, G. P. Page, E. Petretto, and V. van Noort. 2009. Repeatability of published microarray gene expression analyses. Nature Genetics 41(2):149-155.
Kesselheim, A. S., C. T. Robertson, J. A. Myers, S. L. Rose, V. Gillet, K. M. Ross, R. J. Glynn, S. Joffe, and J. Avorn. 2012. A randomized study of how physicians interpret research funding disclosures. New England Journal of Medicine 367(12):1119-1127.
Kirwan, B. A., J. Lubsen, S. de Brouwer, F. J. van Dalen, S. J. Pocock, T. Clayton, N. Danchin, P. A. Poole-Wilson, and ACTION (A Coronary disease Trial Investigating Outcome with Nifedipine GITS) Investigators. 2008. Quality management of a large randomized double-blind multi-centre trial: The ACTION experience. Contemporary Clinical Trials 29(2):259-269.
Krumholz, H. M., Y. Wang, J. Chen, E. E. Drye, J. A. Spertus, J. S. Ross, J. P. Curtis, B. K. Nallamothu, J. H. Lichtman, E. P. Havranek, F. A. Masoudi, M. J. Radford, L. F. Han, M. T. Rapp, B. M. Straube, and S. L. Normand. 2009. Reduction in acute myocardial infarction mortality in the United States: Risk-standardized mortality rates from 1995-2006. JAMA 302(7):767-773.
Laine, C., S. N. Goodman, M. E. Griswold, and H. C. Sox. 2007a. Reproducible research: Moving toward research the public can really trust. Annals of Internal Medicine 146(6):450-453.
Laine, C., R. Horton, C. D. DeAngelis, J. M. Drazen, F. A. Frizelle, F. Godlee, C. Haug, P. C. Hébert, S. Kotzin, A. Marusic, P. Sahni, T. V. Schroeder, H. C. Sox, M. B. Van der Weyden, and F. W. Verheugt. 2007b. Clinical trial registration—looking back and moving ahead. New England Journal of Medicine 356(26):2734-2736.
McCullough, P. A., and N. E. Lepor. 2005. The deadly triangle of anemia, renal insufficiency, and cardiovascular disease: Implications for prognosis and treatment. Reviews in Cardiovascular Medicine 6(1):1-10.
Michele, T. M., S. Pinheiro, and S. Iyasu. 2010. The safety of tiotropium—the FDA’s conclusions. New England Journal of Medicine 363(12):1097-1099.
NRC (National Research Council). 2010. A foundation for evidence-driven practice: A rapid learning system for cancer care: Workshop summary. Washington, DC: The National Academies Press.
Peng, R. D., F. Dominici, and S. L. Zeger. 2006. Reproducible epidemiologic research. American Journal of Epidemiology 163(9):783-789.
Piwowar, H. A., R. S. Day, D. and B. Fridsma. 2007. Sharing Detailed Research Data Is Associated with Increased Citation Rate. PLoS ONE 2(3):e308.doi:10.1371/journal.pone.0000308
Platt, R. 2012. Distributed networks can facilitate working remotely with research datasets derived from routinely collected electronic health information, often eliminating the need to transfer sensitive data. Presentation at IOM Workshop on Sharing Clinical Research Data, October 4-5, Washington, DC.
Riley, R. D., P. C. Lambert, and G. Abo-Zaid. 2010. Meta-analysis of individual participant data: Rationale, conduct, and reporting. BMJ 340:c221.
Rodwin, M. A., and J. D. Abramson. 2012. Clinical trial data as a public good. JAMA 308(9):871-872.
Savage C. J., and A. J. Vickers. 2009. Empirical Study of Data Sharing by Authors Publishing in PLoS Journals. PLoS ONE 4(9):e7078. doi:10.1371/journal.pone.0007078.
Silverstein, F. E., G. Faich, J. L. Goldstein, L. S. Simon, T. Pincus, A. Whelton, R. Makuch, G. Eisen, N. M. Agrawal, W. F. Stenson, A. M. Burr, W. W. Zhao, J. D. Kent, J. B. Lefkowith, K. M. Verburg, and G. Geis. 2000. Gastrointestinal toxicity with celecoxib vs nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: The CLASS study: A randomized controlled trial. JAMA 284(10):1247-1255.
Singh, S., Y. K. Loke, and C. D. Furberg. 2008. Inhaled anticholinergics and risk of major adverse cardiovascular events in patients with chronic obstructive pulmonary disease: A systematic review and meta-analysis. JAMA 300(12):1439-1450. Erratum in: JAMA, 2009, 301(12):1227-1230.
Vickers, A. J. 2006. Whose data set is it anyway? Sharing raw data from randomized trials. Trials 7:15.
Wagner, J. A., E. C. Wright, M. M. Ennis, M. Prince, J. Kochan, D. J. Nunez, B. Schneider, M. D. Wang, Y. Chen, S. Ghosh, B. J. Musser, and M. T. Vassileva. 2009. Utility of adiponectin as a biomarker predictive of glycemic efficacy is demonstrated by collaborative pooling of data from clinical trials conducted by multiple sponsors. Clinical Pharmacology & Therapeutics 86(6):619-625.
Walport, M., and P. Brest. 2011. Sharing research data to improve public health. Lancet 377(9765):537-539.
Williams, B., V. Entwistle, G. Haddow, and M. Wells. 2008. Promoting research participation: Why not advertise altruism? Social Science & Medicine 66(7):1451-1456.
Zarin, D. A. 2012. Information loss as clinical trials data progresses from raw uncoded data to summary data. Presentation at IOM workshop on Sharing Clinical Research Data, October 4-5, Washington, DC.
Zarin, D. A., T. Tse, R. J. Williams, R. M. Califf, and N. C. Ide. 2011. The ClinicalTrials.gov results database—update and key issues. New England Journal of Medicine 364(9):852-860.